EU likely to decline new vaccine deals with Astrazeneca and J&J
The EU is negotiating with Pfizer/Biontech and Moderna for new vaccine contracts, states French economy minister, but it's unlikely the union it will reach out to Astrazeneca or Johnson & Johnson.
BY RITZAU, TRANSLATED BY NIELSINE NIELSEN
It improbable that the EU will renew its vaccine contract with British-Swedish Astrazeneca, and no negotiations have been entered into with US giant Johnson & Johnson either, says Secretary of State for Economy and Finance Agnes Pannier-Runacher, according to news agency AFP.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
